Evidence map›Paper›PMID 35651606›Full record

ArticleFrontiers in immunology2022

Dissecting Tissue Compartment-Specific Protein Signatures in Primary and Metastatic Oropharyngeal Squamous Cell Carcinomas.

Habib Sadeghirad, James Monkman, Ahmed M Mehdi, Rahul Ladwa, Ken O'Byrne, Brett G M Hughes, Arutha Kulasinghe

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Habib SadeghiradThe University of Queensland Diamantina Institute, The University of Queensland, Woolloongabba, QLD, Australia.
James MonkmanThe University of Queensland Diamantina Institute, The University of Queensland, Woolloongabba, QLD, Australia.
Ahmed M MehdiThe University of Queensland Diamantina Institute, The University of Queensland, Woolloongabba, QLD, Australia.
Rahul LadwaPrincess Alexandra Hospital, Woolloongabba, QLD, Australia.
Ken O'ByrnePrincess Alexandra Hospital, Woolloongabba, QLD, Australia.
Brett G M HughesFaculty of Medicine, University of Queensland, Herston, QLD, Australia.
Arutha KulasingheThe University of Queensland Diamantina Institute, The University of Queensland, Woolloongabba, QLD, Australia.
The University of Queensland · AUPrincess Alexandra Hospital · AUQCIF Ltd. · AURoyal Brisbane and Women's Hospital · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Head and neck squamous cell carcinoma (HNSCC) often presents with locoregional or distant disease, despite multimodal therapeutic approaches, which include surgical resection, chemoradiotherapy, and more recently, immunotherapy for metastatic or recurrent HNSCC. Therapies often target the primary and nodal regional HNSCC sites, and their efficacy at controlling occult distant sites remains poor. While our understanding of the tumor microenvironment conducive to effective therapies is increasing, the biology underpinning locoregional sites remains unclear. Here, we applied targeted spatial proteomic approaches to primary and lymph node metastasis from an oropharyngeal SCC (OPSCC) cohort to understand the expression of proteins within tumors, and stromal compartments of the respective sites in samples of both matched and unmatched patients. In unmatched analyses of n = 43 primary and 11 nodal metastases, our data indicated that tumor cells in nodal metastases had higher levels of Ki-67, PARP, BAD, and cleaved caspase 9, suggesting a role for increased proliferation, DNA repair, and apoptosis within these metastatic cells. Conversely, in matched analyses (n = 7), pro-apoptotic markers BIM and BAD were enriched in the stroma of primary tumors. Univariate, overall survival (OS) analysis indicated CD25 in tumor regions of primary tumors to be associated with reduced survival (HR = 3.3, p = 0.003), while progesterone receptor (PR) was associated with an improved OS (HR = 0.33, p = 0.015). This study highlights the utility of spatial proteomics for delineating the tumor and stromal compartment composition, and utility toward understanding these properties in locoregional metastasis. These findings indicate unique biological properties of lymph node metastases that may elucidate further understanding of distant metastatic in OPSCC.

Indexed as

Carcinoma, Squamous CellHead and Neck NeoplasmsHumansLymphatic MetastasisNeoplasm Recurrence, LocalProteomicsSquamous Cell Carcinoma of Head and NeckTumor Microenvironmentdigital spatial profilinghead and neck cancerlymph node metastasismetastasisoropharangeal cancerspatial proteomics

Identifiers

PMID35651606
PMCPMC9149425
OpenAlexW4280535697

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.